Brimonidine Tartrate Solution/ Drops
Product Images NDC 24208-411

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 24208-411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6c8473d2 340c 4861 Ac53 D715b52ca139 00

6c8473d2 340c 4861 Ac53 D715b52ca139 00
This is a product description of Brimonidine Tartrate Ophthalmic Solution with a concentration of 0.2% for topical use in ophthalmology. The dosage instructions and some product codes are provided, including the NDC code. There is a warning given, but the specific meaning of it is not clear.*
FDA Label Image

Dbad897a 1c53 4cf2 836d C99c0bdfc1ba 00

Dbad897a 1c53 4cf2 836d C99c0bdfc1ba 00
This text is a warning that indicates that a particular product should not be used if it does not have an intact yellow protective seal imprinted with an asterisk.*
FDA Label Image

Image 01

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.